tetano
Editor, Senior Moderator
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):139-146.
[Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)].
[Article in Chinese]
Chen Z[SUP]1[/SUP], Fu J[SUP]1[/SUP], Shu Q[SUP]1[/SUP], Wang W[SUP]1[/SUP], Chen Y[SUP]1[/SUP], Hua C[SUP]1[/SUP], Li F[SUP]1[/SUP], Lin R[SUP]1[/SUP], Tang L[SUP]1[/SUP], Wang T[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Xu W[SUP]1[/SUP], Yang Z[SUP]1[/SUP], Ye S[SUP]1[/SUP], Yuan T[SUP]1[/SUP], Zhang C[SUP]1[/SUP], Zhang Y[SUP]1[/SUP].
Author information
Abstract
The coronavirus disease 2019 (COVID-19) has caused a global pandemic. All people including children are generally susceptible to COVID-19, but the condition is relatively mild for children. The diagnosis of COVID-19 is largely based on the epidemiological evidence and clinical manifestations, and confirmed by positive detection of virus nucleic acid in respiratory samples. The main symptoms of COVID-19 in children are fever and cough; the total number of white blood cell count is usually normal or decreased; the chest imaging is characterized by interstitial pneumonia, which is similar to other respiratory virus infections and Mycoplasma pneumoniae infections. Early identification, early isolation, early diagnosis and early treatment are important for clinical management. The treatment of mild or moderate type of child COVID-19 is mainly symptomatic. For severe and critical ill cases, the oxygen therapy, antiviral drugs, antibacterial drugs, glucocorticoids, mechanical ventilation or even extracorporeal membrane oxygenation (ECMO) may be adopted, and the treatment plan should be adjusted timely through multi-disciplinary cooperation.
PMID:32391657
[Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)].
[Article in Chinese]
Chen Z[SUP]1[/SUP], Fu J[SUP]1[/SUP], Shu Q[SUP]1[/SUP], Wang W[SUP]1[/SUP], Chen Y[SUP]1[/SUP], Hua C[SUP]1[/SUP], Li F[SUP]1[/SUP], Lin R[SUP]1[/SUP], Tang L[SUP]1[/SUP], Wang T[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Xu W[SUP]1[/SUP], Yang Z[SUP]1[/SUP], Ye S[SUP]1[/SUP], Yuan T[SUP]1[/SUP], Zhang C[SUP]1[/SUP], Zhang Y[SUP]1[/SUP].
Author information
Abstract
The coronavirus disease 2019 (COVID-19) has caused a global pandemic. All people including children are generally susceptible to COVID-19, but the condition is relatively mild for children. The diagnosis of COVID-19 is largely based on the epidemiological evidence and clinical manifestations, and confirmed by positive detection of virus nucleic acid in respiratory samples. The main symptoms of COVID-19 in children are fever and cough; the total number of white blood cell count is usually normal or decreased; the chest imaging is characterized by interstitial pneumonia, which is similar to other respiratory virus infections and Mycoplasma pneumoniae infections. Early identification, early isolation, early diagnosis and early treatment are important for clinical management. The treatment of mild or moderate type of child COVID-19 is mainly symptomatic. For severe and critical ill cases, the oxygen therapy, antiviral drugs, antibacterial drugs, glucocorticoids, mechanical ventilation or even extracorporeal membrane oxygenation (ECMO) may be adopted, and the treatment plan should be adjusted timely through multi-disciplinary cooperation.
PMID:32391657